Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Category
US Equities - Factor & Thematic
Sponsor
Themes ETFs
Fund Family
Index
Solactive US R&D Champions Index
Index Weighting
Active/Passive
Expense
0.29%
Inverse/Leveraged
IPO
Dec 13, 2023
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / No
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
1.32%
SMA50
2.41%
SMA200
11.61%
Return% 1Y
18.94%
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
0.00%
Flows% 3M
0.00%
Flows% YTD
0.00%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
51
AUM
1.16M
NAV/sh
52W High
40.38 -5.08%
52W Low
30.31 26.47%
Volatility
0.20% 0.21%
ATR (14)
0.40
RSI (14)
54.76
Beta
1.28
Rel Volume
0.00
Avg Volume
0.14K
Volume
0
Perf Week
-0.86%
Perf Month
4.33%
Perf Quarter
19.85%
Perf Half Y
13.37%
Perf YTD
15.14%
Perf Year
18.51%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
38.33
Price
38.33
Change
0.00%
Themes US R&D Champions ETF seeks to track the performance, before fees and expenses, of the Solactive US R&D Champions Index. The index is designed to provide exposure to U.S. companies in the large- and mid- capitalization segments that rank in the top 50 companies based on the index Provider's R&D intensity metric. The fund will invest, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities that comprise the index. The fund is non-diversified.